Editorial from Biotech Daily, page-59

Please bear with me, I know nothing about biotech. I mean, I believe that people at Celgene, one of the largest company in the world, know more than me about the value of Mesoblast stem cell research and the potential to cure human disease. That way, when I knew that Celgene paid AUD 3.82/share for 15.3 millions shares of Mesoblast and Mesoblast shares gone down to AUD 3.40, I was thinking to buy the shares. As it's about 10% cheaper than what the smart guys paid. (Un)Fortunately I was not able to buy the shares as Mesoblast shares in trading halt. My opinion about those guys in Celgene remain the same, and don't blame me if now I feel smarter than those guys coz I can buy the same shares at a much cheaper price than what they paid few months ago ( and the company in a more advanced stage).